SurModics Announces Commencement of Tender Offer to Purchase up to $55 Million of Its Common Stock
08:00 EDT 6 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industries, today announced it has commenced a tender offer to purchase
up to $55 million of its co...
Other Sources for this Article
SurModics, Inc.
Tim Arens, 952-500-7000
Vice President of
Finance and Interim Chief Financial Officer
More From BioPortfolio on "SurModics Announces Commencement of Tender Offer to Purchase up to $55 Million of Its Common Stock"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
